• LAST PRICE
    0.9500
  • TODAY'S CHANGE (%)
    Trending Up0.0400 (4.3956%)
  • Bid / Lots
    0.9401/ 1
  • Ask / Lots
    0.9650/ 20
  • Open / Previous Close
    0.9799 / 0.9100
  • Day Range
    Low 0.9005
    High 0.9799
  • 52 Week Range
    Low 0.4700
    High 1.7700
  • Volume
    163,358
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.91
TimeVolumePRPO
09:32 ET199130.9798
09:33 ET208290.9102
09:35 ET7000.97
09:39 ET3490.9107
09:42 ET2000.95
09:44 ET41040.94
09:46 ET29100.9101
09:48 ET47140.94
10:02 ET26750.95
10:04 ET91500.94
10:06 ET18000.9102
10:08 ET3500.9102
10:15 ET134000.9105
10:22 ET201500.92
10:24 ET6000.9301
10:26 ET8000.9401
10:33 ET11000.92
10:36 ET1000.9299
10:40 ET11000.9207
10:42 ET4000.92
10:54 ET50820.91
10:56 ET5760.9005
10:58 ET8000.9098
11:02 ET26240.9199
11:03 ET26000.9175
11:12 ET15000.9419
11:20 ET1000.9499
11:34 ET5000.95
11:43 ET148550.9338
11:54 ET22500.9338
11:56 ET20000.9338
12:10 ET5000.96
12:17 ET31000.9575
12:19 ET26730.959899
12:21 ET16200.9578
12:24 ET26000.9578
12:26 ET19000.9599
12:30 ET8800.955
12:32 ET33000.955
12:33 ET39760.94
12:44 ET9030.94
12:51 ET3170.95
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPRPO
Precipio Inc
20.8M
-1.8x
---
United StatesHTGM
HTG Molecular Diagnostics Inc
9.7M
-0.2x
---
United StatesEKSO
Ekso Bionics Holdings Inc
22.2M
-1.4x
---
United StatesAVGR
Avinger Inc
10.0M
-0.3x
---
United StatesNUWE
Nuwellis Inc
4.6M
-0.1x
---
United StatesAPYI
Arypsa Inc
8.5K
0.0x
---
As of 2023-02-01

Company Information

Precipio, Inc. is a healthcare solutions company that is focused on cancer diagnostics. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing. IV-Cell is a media that enables culturing of all four hematopoietic cell lineages, which include myeloid cells, B-cells, T-cells and plasma cells. The diagnostic process of hematopoietic diseases involves chromosomal analysis by conducting cell-culture-based tests in a cytogenetics laboratory to imitate in-vivo conditions. HemeScreen technology was developed by the Company targeting Myeloproliferative Neoplasms (MPN), which has evolved into a suite of robust genetic diagnostic panels. ICP technology was developed at Harvard and is licensed exclusively by Dana-Farber. Its laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha.

Contact Information

Headquarters
12325 Emmet StOMAHA, NE, United States 68164-4243
Phone
203-787-7888
Fax
302-655-5049

Executives

Independent Chairman of the Board
Richard Sandberg
Chief Executive Officer, Founder, Director
Ilan Danieli
Interim Chief Financial Officer
Matthew Gage
Chief Operations Officer
Ahmed Zaki Sabet
Chief Legal Counsel and People Officer
Miri Chiko-radomski

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$20.8M
Revenue (TTM)
$9.5M
Shares Outstanding
22.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.34
EPS
$-0.53
Book Value
$1.08
P/E Ratio
-1.8x
Price/Sales (TTM)
2.2
Price/Cash Flow (TTM)
---
Operating Margin
-141.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.